Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Biomerieux SA

BMXMF
Current price
122.5 USD 0 USD (0.00%)
Last closed 110.1 EUR
ISIN FR0013280286
Sector Healthcare
Industry Diagnostics & Research
Exchange PA
Capitalization 12 992 966 696 EUR
Yield for 12 month +18.71 %
1Y
3Y
5Y
10Y
15Y
BMXMF
21.11.2021 - 28.11.2021

bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries. It also provides a suite of software products and services that collect, analyze, and merge various sources of data to make decisions under the BIOMÉRIEUX VISION SUITE name; designs, manufactures, and maintains instruments and software; and designs and manufactures reagents for in vitro diagnostic tests. The company serves clinical and hospital laboratories, physicians, blood banks, vets, and industrial control laboratories. bioMérieux S.A. was formerly known as B-D Mérieux. The company was founded in 1963 and is headquartered in Marcy-l'Étoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA. Address: 376 Chemin De l?Orme, Marcy-l'Étoile, France, 69280

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

103.28 EUR

P/E ratio

31.7291

Dividend Yield

0.77 %

Current Year

+3 674 843 085 EUR

Last Year

+3 589 239 751 EUR

Current Quarter

+1 901 974 056 EUR

Last Quarter

+1 904 674 161 EUR

Current Year

+1 886 773 464 EUR

Last Year

+1 961 176 360 EUR

Current Quarter

+1 045 140 694 EUR

Last Quarter

+971 137 813 EUR

Key Figures BMXMF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 863 533 655 EUR
Operating Margin TTM 15.16 %
PE Ratio 31.7291
Return On Assets TTM 7.08 %
PEG Ratio 2.9045
Return On Equity TTM 10.61 %
Wall Street Target Price 103.28 EUR
Revenue TTM 3 806 648 312 EUR
Book Value 32.78 EUR
Revenue Per Share TTM
Dividend Share 0.85 EUR
Quarterly Revenue Growth YOY 7.4 %
Dividend Yield 0.77 %
Gross Profit TTM 2 008 778 214 EUR
Earnings per share 3.47 EUR
Diluted Eps TTM 3.47 EUR
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY 34.1 %
Profit Margin 10.81 %

Dividend Analytics BMXMF

Dividend growth over 5 years

150 %

Continuous growth

Payout Ratio 5 years average

17 %

Dividend History BMXMF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 0.85
Ex Dividend Date 07.06.2024
Forward Annual Dividend Yield 0.77 %
Last Split Factor 3:1
Payout Ratio 24.5 %
Last Split Date 20.09.2017
Dividend Date

Stock Valuation BMXMF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 31.7291
Forward PE 24.3902
Enterprise Value Revenue 3.4886
Price Sales TTM 3.4132
Enterprise Value EBITDA 18.2752
Price Book MRQ 3.3591

Financials BMXMF

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators BMXMF

For 52 weeks

83.79 EUR 111.5 EUR
50 Day MA 99.46 EUR
Shares Short Prior Month
200 Day MA 98.89 EUR
Short Ratio
Shares Short
Short Percent